NMC was the worst performing FTSE 100 stock in 2019. Should I buy it?

first_imgNMC was the worst performing FTSE 100 stock in 2019. Should I buy it? I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Simply click below to discover how you can take advantage of this. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! “This Stock Could Be Like Buying Amazon in 1997” Jonathan Smith | Tuesday, 7th January, 2020 | More on: NMC Now that 2019 has come to a close, taking stock of both the good and the bad can give us various lessons to take forward into 2020. I have already written a piece looking at the star performer from the FTSE 100 index last year, which you can read here.However, it is also worth reviewing the worst performer, and seeing what we can spot to avoid when making investment choices this year.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Firstly, it is actually quite hard to pinpoint the specific ‘worst performer’ as the FTSE 100 relegates companies that have a sharp drop in the share price (and thus the market capitalisation) down to the FTSE 250 on a quarterly basis. For example, Marks and Spencer was in the FTSE 100 at this time last year, but dropped out in Q3. Then there is the issue of whether to include dividends in the performance, or the exact date range we choose.To keep it clean, I’ve used the numbers of the companies that were in the FTSE 100 for all of last year, to give a fair comparison. In this case, the wooden spoon goes to NMC Health (LSE: NMC). It is the largest healthcare provider in the Middle East, but also has a network of hospitals in Europe.This time last year it was trading at 2,620p, and opened in the New Year at 1,800p. This is a fall of some 31.3%.What happened here?Taking the performance over an annualised period as we have done usually smooths out a bumpy road, but not so for NMC. For most of last year, the share price was fairly muted. If you had checked your portfolio containing NMC in May or September then it would have shown you a profit (assuming you bought it at the start of 2019). The real kick in the teeth that saw it take the booby prize came just last month. The share price dropped by almost 50% following a report about the validity of the company’s financial statements from Muddy Waters. Muddy Waters calls itself a “due diligence based equity research” firm, and has been in the news previously for questioning or exposing company practices. The firm claimed that NMC had potentially overpaid on acquisitions, inflated its margins and understated reported debt. The market reacted fast, with the share price yet to make a meaningful bounce back.Should I buy it?At the moment, I do not believe that retail investors such as myself have enough information on what is true or not. NMC called the report by Muddy Waters “false and misleading” and has opened its books for independent review. If the business has nothing to hide, then sure the current share price makes it cheap on a relative basis if the company is actually in good financial health.However, if NMC does have problems (Muddy Waters claim it has understated debt of $320m as of 2018) then this could be a serious can of worms that could see the share price tumble further. On balance, without more publicly available information, buying into NMC seems more of a gamble than an investment to me at the moment. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.center_img Our 6 ‘Best Buys Now’ Shares Jonathan Smith does not own shares in NMC Health. The Motley Fool UK owns shares of and has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Enter Your Email Address Image source: Getty Images. See all posts by Jonathan Smithlast_img read more

Detailed guide: Good manufacturing practice and good distribution practice

first_img interview relevant personnel review documents conduct site visits Co-ordination group for Mutual Recognition and Decentralised Procedures – human (CMDh). Types of inspectionInspections under the risk-based compliance programmeEvery manufacturer and wholesaler has a risk rating or score and we prioritise inspections for those with the highest ratings or scores. You will be told about these inspections in advance, although under the short-notice inspection programme we may send little or no notification. At the inspection, GMP and/or GDP inspectors examine the systems used to manufacture and/or distribute medicines.Your GMP rating is based on: Good distribution practice (GDP) requires that medicines are obtained from the licensed supply chain and are consistently stored, transported and handled under suitable conditions, as required by the MA or product specification.Organisations that may have to comply with good manufacturing practice (GMP) and/or good distribution practice (GDP) include: You can’t appeal against your rating.An increase in risk will be peer reviewed by a GMP operations manager, a member of the compliance management team (CMT) or a GMP expert inspector before being finalised.You will be given a full copy of the reasons for your risk rating once the inspection has closed.For GDP inspections your risk score is based on what activities take place on site and the number and type of deficiencies observed. This indicates the likely date of your next inspection and this information is included on the inspection report.Inspections may sometimes be carried out with other MHRA inspections, such as with good clinical practice or good pharmacovigilance practice.Product-related GMP inspectionsMHRA conducts product-related GMP inspections when assessing an application for a UK marketing authorisation. This inspection checks if the manufacturer complies with GMP. We tell you about this inspection in advance.Product-related inspections can also be requested by the European Medicines Agency (EMA): Guidance for UK manufacturer’s licence and manufacturer’s authorisation holders (for investigational medicinal products) – on the use of stand alone contract laboratories (PDF, 185KB, 3 pages) – on the use of stand alone contract laboratories manufacturing areas quality control (QC) laboratories stock and stock management storage areas temperature monitoring returns areas purchasing and sales functions transportation arrangements GDP compliance report (MS Word Document, 251KB) GMP pre-inspection compliance report (MS Word Document, 404KB) GMP interim compliance report (MS Word Document, 342KB) GMP compliance report and interim update guidance (PDF, 104KB, 7 pages) GMP Quality Control Laboratory Pre-Inspection Compliance Report (MS Word Document, 56.2KB) GMP QC compliance report and interim update guidance (PDF, 156KB, 6 pages) your compliance report internal information about previous inspection history organisational changes MHRA carries out inspections to check if manufacturing and distribution sites comply with GMP or GDP. You will be inspected when you apply for a manufacturer or wholesaler dealer licence and then periodically based on risk assessments. Overseas manufacturing sites are also inspected.If an organisation manufactures or distributes both human and veterinary medicines, MHRA may carry out an inspection of both areas on behalf of the Veterinary Medicines Directorate.MHRA and the European Medicines Agency (EMA) have published guidance on GMP and GDP. Site visits may include any facility or process involved in producing, purchasing and distributing medicines, including: OverviewGood manufacturing practice (GMP) is the minimum standard that a medicines manufacturer must meet in their production processes. Products must: Volume 4 of the rules governing medicinal products in the EU be of consistent high quality be appropriate to their intended use meet the requirements of the marketing authorisation (MA) or product specification manufacturer licence holders wholesale dealer licence holders blood establishment authorisation holders non-UK sites employed by UK MA holderscenter_img EMA uses inspectors from EU member states to ensure compliance with GMP principles.Triggered inspectionsMHRA may inspect you if we’re informed about possible GMP or GDP breaches by: We may send little or no notification of these inspections in advance.Complete a compliance reportYou will have to complete either a GDP or GMP compliance report before an before an inspection unless it is a triggered inspection which are only notified at short notice.You should send completed compliance reports to the email address given by the inspector. Hard copies of compliance reports will not be accepted. a whistle blower other MHRA departments another regulatory authority OtherA deficiency which cannot be classified as either critical or major or there is not enough information to classify it as critical or major but which indicates a departure from good manufacturing and distribution practice.Actions after the inspectionAfter the inspection closing meeting, you will receive a post inspection letter confirming any deficiencies found.You must respond to the inspector by email to confirm the proposed corrective actions and dates for when these actions will be completed. The inspector will review your response. If they accept it, you will receive a GMP or GDP certificate with your inspection report. An unacceptable response may lead to compliance escalation if further requests for information are unsatisfactory.If you’re being inspected for GMP you should complete an interim assessment if there are changes to your site following your first inspection.Guidance on responding to a post-inspection letterThe daily rate inspection fee includes preparation for, reporting and close-out of the inspection. Inspections with critical findings or other significant non-compliance requiring referral to the GMDP Compliance Management Team and/or Inspection Action Group may require the inspector(s) to spend additional time beyond that covered by the daily rate overseeing the adequacy of the company’s Corrective and Preventative Actions (CAPA) and the company’s return to compliance. For such inspections, an office-based inspection fee may be charged for this additional time spent by the inspector(s) on such activities (for example, reviewing CAPA plans, impact assessments and periodic CAPA status updates).Compliance escalation processIf your compliance is found to be poor but has not hit the threshold for regulatory action you may go through the compliance escalation process. The aim of this process is to support companies to achieve compliance before regulatory action becomes necessary.Once the process has been completed you will be returned to the routine risk-based inspection programme. However you could still be referred for regulatory action if you do not make the necessary improvements.The process may also be used if the Inspection Action Group has closed their case referral but the company to be monitored until remedial action plans have been completed.The process may include: The inspectionDuring an inspection the inspection team will: making recommendations on close monitoring of compliance improvement work through inspection meetings and correspondence with company senior management clearly outlining the consequences of continued non-compliance has or may produce a product that doesn’t comply with its marketing authorisation indicates a major deviation from GMP or GDP or from the terms of the manufacturer licence or wholesale licence indicates a failure to carry out satisfactory batch release procedures or (within EU) a failure of the Qualified Person or Responsible Person to fulfil their legal duties a combination of several ‘other’ deficiencies which on their own may not be major but together may represent a major deficiency and should be explained and reported as such Committee for Human Medicinal products (CHMp) during the pre-application of a centralised marketing authorisation application Information on new arrangements for inspections during the coronavirus (COVID-19) outbreak. Exceptional good distribution practice (GDP) flexibilities for medicines during the coronavirus (COVID-19) outbreak EU GDP guidelines. Orange Guide: Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 Green Guide: Rules and Guidance for Pharmaceutical Distributors 2017. The inspection team may ask for additional documentation and samples for testing during the inspection. They may also change the focus of the inspection if they suspect serious non-compliance.At the closing meeting the inspector will provide feedback and discuss any deficiencies with you and agree timelines for corrective actions.Grading of inspection findingsDeficiencies found during inspections are graded at 3 levels. The definitions below are summaries. For the full definition see page 47 of the EMA compilation of community procedures on inspections and exchange of informationCritical deficiencyA deficiency which has produced or significantly risks producing a product which is harmful to humans or veterinary patients or which could result in a harmful residue in a food-producing animal.Any departure from good distribution practice that results in a significant risk to patients. This includes an activity which increases the risk of counterfeit medicines reaching patients.Major deficiencyA non-critical deficiency which: Information sheetsRe-inspection of site under Compliance Management (PDF, 29.3KB, 1 page)Compliance Management – Specials Manufacturers (PDF, 36.1KB, 1 page)Compliance Management – MIA MIA(IMP) and third country manufacture (PDF, 37.4KB, 2 pages)Compliance Management – Contract Laboratory (PDF, 29.4KB, 1 page)Compliance Management – Active Substance (PDF, 29.6KB, 1 page)Regulatory action – UK Wholesaler (PDF, 83.7KB, 2 pages)Feedback from GMP inspectionsTo help you understand the areas where GMP inspectors have found compliance problems during GMP inspections in the UK and overseas, the GMP inspectorate produces a report of common deficiencies from previous GMP inspections.The GMP Inspectorate has compiled an anonymised raw data set, so that stakeholders can do their own tailored analysis of our findings specific to their supply chain.Suspension of your licenceIf the inspector finds critical deficiencies or that agreed action plans from previous inspection deficiencies have not been resolved they will contact the Inspection Action Group (IAG). The IAG can refuse or suspend your licence, increase inspection visits or request a meeting with the licence holder.Information SheetsRe-inspection of site under Regulatory Action (PDF, 32.4KB, 1 page)Regulatory Action – Specials manufacturers (PDF, 37.9KB, 2 pages)Regulatory Action – MIA MIA(IMP) and Third Country manufacture (PDF, 39.5KB, 2 pages)Regulatory Action Contract Laboratory (PDF, 33.6KB, 2 pages)Regulatory Action – Active Substance (PDF, 34.1KB, 2 pages)Deficiency data (2018) (MS Excel Spreadsheet, 456KB)Transitional Qualified Persons (QPs) for investigational medicinal products (IMPs)We are aware there is some concern for UK business and personal careers, over the status of transitional QPs that were recognised under the transitional arrangements provided in SI 2004/1031, when the Clinical Trials Directive was implemented in 2004. Under the Clinical Trials Regulation EU No. 536/2014 Article 61, 2b., QPs will need to fulfil the conditions of qualification set out in Article 49(2) and (3) of Directive 2001/83/EC. The GMDP Inspectorate has worked closely with MHRA’s legal advisors to ensure that the original qualification eligibility assessments made between 2004-2006 remain valid, and that transitional QPs can continue to be considered eligible where their qualifications are also supported by at least 2 years practical experience from working in a licenced manufacturing facility.The GMDP Inspectorate have launched a reassessment process to give transitional QPs for IMP the opportunity to demonstrate how they now meet Article 49(2) & (3) of Directive 2001/83/EC, in line with the requirements of EU Regulation 536/2014 and applicants will need to complete the Transitional Qualified Persons reassessment form (MS Word Document, 374KB). This information will be used to provide a summary of qualifications and work experiences of acting in a transitional QP role to date, and will be added to information provided with the original 2004 – 2006 applications. There is no charge for the application and completed forms should be emailed to [email protected] for assessment. Following assessment, eligibility certificates will be issued to those meeting the requirements set out in set out in Article 49(2) and (3) of Directive 2001/83/EC.The reassessment process only applies to applicants who were assessed and acknowledged as transitional QPs under the SI 2004/1031 arrangements, which means transitional QPs that have been named as a QP in a valid application for a manufacturing authorisation for IMPs made prior to 1st May 2006 under the Medicines for Human Use (Clinical Trials) Regulations 2004 (SI 2004/1031). This scheme is not open to any new trainee QPs wanting to specialise in the IMP sector, who would need to apply for eligibility assessment through the Joint Professional Bodies category A assessment route.Fees for inspectionFees for GMP and GDP inspections.ContactFor further information on good manufacturing and distribution practices, email [email protected] or [email protected] further information on the planning of GMP inspections, email [email protected] and for GDP inspections [email protected] inspections from 1 January 2021From 1 January 2021, the MHRA’s GxP risk-based inspection programmes will remain unchanged.GMP inspection outcomes from EEA regulatory authorities will continue to be recognised under a new mutual recognition agreement.Inspections performed by existing mutual recognition partners will also continue to be accepted, if they are within the scope of the mutual recognition agreement in place before 1 January 2021.last_img read more

Danish energy giant makes a $580 million move into U.S. wind

first_img FacebookTwitterLinkedInEmailPrint分享Energy Digital:Danish energy company Ørsted has agreed to purchase US wind and solar company Lincoln Clean Energy for $580mn.Lincoln Clean Energy develops, owns and operates clean power projects which a specific focus on wind and solar. In particular, the company owns a range of onshore wind farms in the US, and currently has a capacity of 513MW within its portfolio. By 2022, total capacity on Lincoln wind farms will reach 1.5GW.Ørsted currently has a 25% global market share in offshore wind and is the leading energy supplier in the UK, with 5,800 employees globally. The firm started a journey to becoming an entirely ‘green’ energy company around 10 years ago.Since then, Ørsted says it has reduced its use of coal by 73% and halved its CO2 emissions. It is currently converting its Danish coal-fired power stations to sustainable biomass, and hopes to be coal free by 2023.Regarding the Lincoln Clean Energy purchase, Ørsted CEO Henrik Poulsen said: “The global market for onshore wind power is expected to grow significantly in the coming years and the US is a leading onshore wind market. The acquisition of Lincoln Clean Energy will provide a strong growth platform in the US, which is one of Ørsted’s strategic growth markets. It is an investment case with healthy economics based on prudent assumptions about key value drivers and market developments.”More: Ørsted to buy Lincoln Clean Energy for $580mn Danish energy giant makes a $580 million move into U.S. windlast_img read more

MBL bill a common-sense boost to economic recovery, Nussle tells lawmakers

first_img 2SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr A bill that would allow credit unions to increase their member business lending (MBL) will be a boost to the economy, CUNA President/CEO Jim Nussle said Tuesday.In a letter to Reps. Ed Royce (R-Calif.) and Gregory Meeks (D-N.Y.), Nussle thanked the legislators for introducing  the bill Monday,“Credit unions understand that in order for the economy to fully recover, small businesses need access to credit, which will help their businesses grow,” Nussle wrote. “Credit unions have capital to lend, a history of prudent and safe small business lending, and a mission to help provide access to credit to their members–including their small business-owning members. They just need Congress to enact your legislation.”Credit unions are currently limited to member business lending up to 12.25% of assets, but if the bill is passed, it could raise the cap to 27.5% of assets for credit unions that meet certain conditions. continue reading »last_img read more


first_imgRecently the Boston Marathon was held on its traditional 3rd Monday of April.  True to its format in the last decade, an Ethiopian won both races.  The only non-Ethiopian on the top of the list was a Kenyan.  Maybe we need to divide marathons into the elite class (North Africans) and the rest of the World.  I can’t remember the last time anyone else had a chance of winning a large marathon.I am kidding, of course, because this would be like prohibiting traditional winners, like the Yankees were in baseball at one time or the Packers in football, from being allowed into the World Series or the Super Bowl because they were winning too often.  The unique physical build of North Africans and the altitude at which they train has put them in this elite category of runners.  The rest of the world is simply going to have to put more emphasis on their practice style and dedication to the art of long-distance running.last_img read more

Top Seven reasons Liverpool will win Premier League Title

first_imgLiverpool have the best defense in the league (Photo by Agency)1- Christmas champions: Forget about a Liverpool slip up.Although in the last ten years the Anfield club is the only side not to win the Premier League after leading at Christmas, the experience of tripping up in 2008/9 and 2013/14 will come in handy.This time there will be no Steven Gerrard slip or poor game management akin to the one witnessed at Selhurst Park where they let a 3-1 advantage melt into a draw.2- Strong record against Top Six: Even before this season, Liverpool manager Jurgen Klopp was comfortably leading the mini league against Top Six rivals.This should come in handy during the second round as Liverpool has mastered the art of annihilating lesser opposition.In the first round, the 18-time champions won every game they played against teams outside the Top Six. Expect more of the same.3- Fabulous front three: Felt for the Kop when they ended up empty handed last season despite their fabulous front three of Mohammed Salah, Roberto Firmino and Sadio Mane bludgeoning over a century of goals.Though they are not quite firing at the same rate, as a triumvirate, they still consistently guarantee more goals than what strikers at title rivals Manchester City and Tottenham Hotspur are offering.I therefore feel the trio are to be compensated for missing out last time.4- Best defense: Eight goals conceded after 20 games of the campaign implies Liverpool can match or beat the all time defensive record of 15 conceded set by Chelsea in 2004/5.In defensive stakes, Virgil van Dirk favourable competes with EPL legends John Terry, Rio Ferdinand, Nemanja Vidic and is a notch better than Jamie Carragher, Sami Hyppia or any other Kop defender since Alan Hansen and Martin Lawrenson.5- Successful signings: Unless Tottenham Hotspur beefs up their squad during the January window, their inability to recruit any players last summer will catch up with them at the tail end of this season.On the other hand, Liverpool’s summer recruits – Alisson Becker, Fabinho, Naby Keita and Xherdhan Shaqiri have come to terms with the league’s demands, ensuring Klopp can have a fresh squad in the home straight.6- High number of players on form: Kop boss Jurgen Klopp is blessed to have such a big number of players operating within their element.Becker, Virgil van Dirk, Andy Robertson, Georgina Wijnaldum, James Milner, Xherdhan Shaqiri and Sadio Mane are all playing to their full potential.This is not the case at Manchester City where a number of their big name players have gone Away Without Leave (AWOL), leaving the burden of expectation on the young shoulders of Raheem Sterling, Bernardo Silva and Leroy Sane.7- Gengenpress: Liverpool’s suffocating, offensive style of play first seen at Borussia Dortmund under Jurgen Klopp is the most demanding approach to the game to both Liverpool and opponents.Kop players thrive best on this heavy metal approach because Klopp has had four years to ingrain it into their blood but it leaves Premier League opponents in a spot of bother.Liverpool squeezes the last bit of sweat out of opponents who simply can’t cope.Comments Tags: liverpoolpremier leaguetoplast_img read more

PRETTYSHOP 100% Human Hair UP DO Ballerina Knoten Donut Bun Topknot Scrunchie Hairpiece Ponytail H311a, really excited when this arrived & hair colour was great match but now its started to unravel & I

first_imgExcellent hair hun, required one particular for a marriage and struggled to locate one particular like this. The colous failed to match accurately so i utilised purple shampoo on it to match it to my hair and it labored flawlessly :).Superb product, great colour, thank you.Excellent hair hun, required one particular for a marriage and struggled to locate one particular like this. The colous failed to match accurately so i utilised purple shampoo on it to match it to my hair and it labored flawlessly :).Key specs for PRETTYSHOP 100% Human Hair UP DO Ballerina Knoten Donut Bun Topknot Scrunchie Hairpiece Ponytail H311a:100% REAL HAIR – human hair. The Real Hair Product is in contrast to a synthetic hair product more resistant, so it has a longer life!Diameter 13cm (5″);Very easy to fixed with an elastic hair ribbon and two small clips to your own pigtailIt can be treated with almost all hair styling appliances and also colored.Please note that the product should not be dyed to lighter shades, but only on dunkelere colors!Washable and easy to comb, natural, soft and comfortable to wear. Shake gently after unpacking and brush to the form and get shut the volume again. The hair residues can be easily brushed out of the hair part.Comments from buyers“Perfect hair bun, Bought 2, they’re so good, excellent product, exactly as advertised”Superb product, great colour, thank you.Genuinely enthusiastic when this arrived & hair color was excellent match but now its started out to unravel & i. Was seriously enthusiastic when this arrived & hair color was excellent match but now its started to unravel & i havent even worn it however?.I acquired one particular and was a little bit doubtful how it would look – as perfectly as apprehensive about the cost. Turns out they are excellent – so good i purchased an additional so i could dress in two. This colour matches my hair correctly as well.Outstanding product or service, particularly as marketed. Exceptional item, specifically as advertised. Unfortunately, i selected a colour that was too light-weight. My fault – so no problems at all.Feels and seems like portion of your have hair and so quick to do.I acquired one particular and was a little bit doubtful how it would look – as perfectly as apprehensive about the cost. Turns out they are excellent – so good i purchased an additional so i could dress in two. This colour matches my hair correctly as well.Feels and seems like portion of your have hair and so quick to do. Genuinely enthusiastic when this arrived & hair color was excellent match but now its started out to unravel & i. Was seriously enthusiastic when this arrived & hair color was excellent match but now its started to unravel & i havent even worn it however?.Outstanding product or service, particularly as marketed. Exceptional item, specifically as advertised. Unfortunately, i selected a colour that was too light-weight. My fault – so no problems at all.last_img read more

Judicial custody for Saradha chit fund scam kingpin


Erasing the past

first_imgAlso sharing the spotlight was libero Kath Arado who negated UST heavy hitter Cherry Rondina, making 32 receptions and 28 digs.The Lady Warriors thus notched their second win in eight games, tying the Tigresses, who are now in danger of missing the Final Four. Police teams find crossbows, bows in HK university PLAY LIST 01:29Police teams find crossbows, bows in HK university01:35Panelo suggests discounted SEA Games tickets for students02:49Robredo: True leaders perform well despite having ‘uninspiring’ boss02:42PH underwater hockey team aims to make waves in SEA Games01:44Philippines marks anniversary of massacre with calls for justice01:19Fire erupts in Barangay Tatalon in Quezon City View comments Pussycat Dolls set for reunion tour after 10-year hiatus Read Next MOST READ One team PH: battle cry of Vargas’ board Brace for potentially devastating typhoon approaching PH – NDRRMC Ateneo also got back at FEU after losing to the Lady Tamaraws in the first round. Both Ateneo and FEU are at 5-3.Jho Maraguinot scored 14 points while Kat Tolentino added 11 points for the Lady Eagles, who also snapped the Lady Tamaraws’ four-win run and muddle up the standings.FEATURED STORIESSPORTSWATCH: Drones light up sky in final leg of SEA Games torch runSPORTSLillard, Anthony lead Blazers over ThunderSPORTSMalditas save PH from shutoutBut it was the startling 25-23, 18-25, 28-26, 26-24 triumph by the Lady Warriors over the Tigresses that created the bigger uproar.It was the first victory of UE over UST in 24 years, and one that UST coach Kungfu Reyes said during the game would go down in infamy for the school. Google honors food scientist, banana ketchup inventor and war hero Maria Orosa Families in US enclave in north Mexico hold sad Thanksgiving LOOK: Iya Villania meets ‘Jumanji: The Next Level’ cast in Mexico Don’t miss out on the latest news and information. John Lloyd Cruz a dashing guest at Vhong Navarro’s wedding LATEST STORIES Maddie Madayag typifies the Lady Eagles’ dominance over Bernadeth Pons, Celine Domingo and the Lady Tams. —SHERWIN VARDELEONAteneo redeemed itself from the heartache of a previous loss but it was University of the East that stole the spotlight as it redeemed itself from the ignominy of the past few seasons Wednesday night.The Lady Eagles bounced back after losing to the defending champion and rival La Salle Lady Spikers by trouncing the Far Eastern University Lady Tamaraws, 25-19, 25-21, 25-17, in the UAAP women’s volleyball at FilOil Flying V Centre.ADVERTISEMENT Typhoon ‘Tisoy’ threatens Games “If we lose here, it’s going to be the most forgettable season for us,” Reyes told the Tigresses early in the fourth when they trailed 12-5. “If you can’t win it for yourselves, at least win it for the school.”That appeared to strike a chord for the Tigresses, who clawed back and even reached set-point, 24-22, on Carla Sandoval’s hit. But in a stunning turn of events that mirrored what happened in the first and third sets, UE came through with clutch hits to steal the match.It was the second straight win for the Lady Warriors, who also defeated the Adamson Lady Falcons to end the first round. UE won one game each the past two seasons.Now they are looking at turning things around after a poor start this year that led to coach Francis Vicente finally calling it quits.Interim coach Rod Roque drew 21 points from Mary Ann Mendres, while Shaya Adorador added 15. Judith Abil and Seth Rodriguez had 10 each.ADVERTISEMENT Typhoon Kammuri accelerates, gains strength en route to PHlast_img read more

Liberals promise First Nation child welfare framework but no new dollars in

first_imgJorge BarreraAPTN National NewsThe federal Liberal budget unveiled Wednesday provided no new funding for First Nations child welfare, but it promised to create an “Indigenous Framework on Early Learning and Child Care” at the conclusion of ongoing consultations with First Nations, Inuit and Metis stakeholders.The Justin Trudeau government is prepared to invest additional dollars into First Nation child welfare and is planning to develop the framework with input from stakeholders before committing to the new funding, said a federal official speaking on background.Finance Minister Bill Morneau would not say when the new money would surface while responding to a question on the issue from APTN host Todd Lamirande during a press conference Wednesday afternoon.“This is of continuing importance to us and this is a dialogue we have to continue,” said Morneau.While Morneau spoke, the Canadian Human Rights Tribunal held a hearing a few blocks away on Ottawa’s failure to comply with a 2016 ruling ordering an end to the discrimination of First Nations children by the continued federal underfunding of on-reserve child welfare services.The hearing was sparked as a result of a non-compliance motion filed by Cindy Blackstock, the head of the First Nations Child and Family Caring Society, the Assembly of First Nations, Nishnawbi Aski Nation and the Chiefs of Ontario.Blackstock and the AFN launched a human rights complaint against Ottawa over its underfunding of First Nations child welfare services in 2007. The human rights complaint also targeted Ottawa’s uneven application of Jordan’s Principle which places the care of First Nations children ahead of jurisdictional disputes over funding.In a recent filing with the tribunal, Ottawa claimed the quasi-judicial body had no authority to control how the federal government chose to spend dollars or interpret how it should comply with the ruling.Blackstock has told APTN she may be forced to seek a contempt order against Ottawa with the Federal Court.Ottawa has argued it is doing all it can on child welfare for the moment. Last year’s budget committed $643 million over five years in new funding for child welfare, with the majority of the dollars flowing in the last two years. The Liberal government set the amount which appeared in the 2016 budget before the tribunal issued its ruling.Indigenous Affairs Minister Carolyn Bennett has said the system needs deep reform, but it won’t happen without more consultations. Bennett has dispatched a ministerial representative to help conduct the [email protected]@JorgeBarreralast_img read more